Targeting the Vulnerabilities of Oncogene Activation

por Huang, Christina, Arbiser, Jack L.
Publicado 2023

MAVS is a double-edged sword

por Huang, Christina, Arbiser, Jack L.
Publicado 2023

Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome

por Huang, Christina, Berghoff, Adar, Arbiser, Jack L.
Publicado 2023

Successful treatment of palmoplantar psoriasis with chemical peeling and gentian violet

por Bubley, Jeffrey A., Alharthi, Maher, Arbiser, Jack L.
Publicado 2021

Mitochondrial Metabolism in Melanoma

por Huang, Christina, Radi, Rakan H., Arbiser, Jack L.
Publicado 2021

Targeting the duality of cancer

por Arbiser, Jack L., Bonner, Michael Y., Gilbert, Linda C.
Publicado 2017

Gentian violet induces wtp53 transactivation in cancer cells

por GARUFI, ALESSIA, D’ORAZI, VALERIO, ARBISER, JACK L., D’ORAZI, GABRIELLA
Publicado 2014

Inhibitors of cytoskeletal dynamics in malignant mesothelioma

por Reis, Katarina, Arbiser, Jack L., Hjerpe, Anders, Dobra, Katalin, Aspenström, Pontus
Publicado 2020

Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis

por Nagalingam, Arumugam, Arbiser, Jack L, Bonner, Michael Y, Saxena, Neeraj K, Sharma, Dipali
Publicado 2012

Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis

por Nagalingam, Arumugam, Arbiser, Jack L., Bonner, Michael Y., Saxena, Neeraj K., Sharma, Dipali
Publicado 2017

Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo

por Bonner, Michael Y., Karlsson, Isabella, Rodolfo, Monica, Arnold, Rebecca S., Vergani, Elisabetta, Arbiser, Jack L.
Publicado 2016

Angiofibroma stimulation in a transgender person receiving gender-affirming testosterone

por Bubley, Jeffrey A., Yeung, Howa, Cole, Emily, Amin, Mariam, Parker, Douglas, Arbiser, Jack L.
Publicado 2020

Indolium 1 Exerts Activity against Vemurafenib-Resistant Melanoma In Vivo

por Radi, Rakan, Huang, Christina, Elsey, Justin, Jung, Yoon H., Corces, Victor G., Arbiser, Jack L.
Publicado 2022

Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer

por Avtanski, Dimiter B., Nagalingam, Arumugam, Bonner, Michael Y., Arbiser, Jack L., Saxena, Neeraj K., Sharma, Dipali
Publicado 2015

Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab

por Westergaard, Sarah A., Lechowicz, Mary Jo, Harrington, Maggie, Elsey, Justin, Arbiser, Jack L., Khan, Mohammad K.
Publicado 2020

SIRT3 activation promotes enteric neurons survival and differentiation

por Balasubramaniam, Arun, Li, Ge, Ramanathan, Anita, Mwangi, Simon Musyoka, Hart, C. Michael, Arbiser, Jack L., Srinivasan, Shanthi
Publicado 2022

Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner

por Avtanski, Dimiter B., Nagalingam, Arumugam, Kuppusamy, Panjamurthy, Bonner, Michael Y., Arbiser, Jack L., Saxena, Neeraj K., Sharma, Dipali
Publicado 2015

Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells

por Metts, Jonathan, Bradley, Heath L., Wang, Zhengqi, Shah, Neil P., Kapur, Reuben, Arbiser, Jack L., Bunting, Kevin D.
Publicado 2017

Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies

por Mędra, Aleksandra, Witkowska, Magdalena, Majchrzak, Agata, Cebula-Obrzut, Barbara, Bonner, Michael Y., Robak, Tadeusz, Arbiser, Jack L., Smolewski, Piotr
Publicado 2016

Palladium based nanoparticles for the treatment of advanced melanoma

por Elsey, Justin, Bubley, Jeffrey A., Zhu, Lei, Rao, Shikha, Sasaki, Maiko, Pollack, Brian P., Yang, Lily, Arbiser, Jack L.
Publicado 2019